Alzheimer's & Dementia: The Journal of the Alzheimer's Association
Volume 5, Issue 5 , Pages 435-436 , September 2009

Commentary on “Alzheimer's disease drug development and the problem of the blood-brain barrier.” The blood-brain barrier: A physical and conceptual challenge

References 

  1. Gladstone DJ, Black SE, Hakim AM. Toward wisdom from failure: lessons from neuroprotective stroke trials and new therapeutic directions. Stroke. 2002;33:2123–2136
  2. Rafii MS, Aisen PS. Recent developments in Alzheimer's disease therapeutics. BMC Med. 2009;7:7
  3. Lee TY, Purdie TG, Stewart E. CT imaging of angiogenesis. Q J Nucl Med. 2003;47:171–187
  4. Aviv RI, d'Esterre C, Murphy B, Hopyan J, Buck B, Mallia G, et al. Hemorrhagic transformation of ischemic stroke: prediction with CT Perfusion. Radiology. 2009;250:867–877
  5. Kassner A, Roberts T, Taylor K, Silver F, Mikuli D. Prediction of hemorrhage in acute ischemic stroke using permeability MR imaging. AJNR. 2005;26:2213–2217
  6. Webb S, Ott RJ, Cherry SR. Quantitation of blood-brain barrier permeability by positron emission tomography. Phys Med Biol. 1989;34:1767–1771
  7. Josserand V, Pélerin H, de Bruin B, Jego B, Kuhnast B, Hinnen F, et al. Evaluation of drug penetration into the brain: a double study by in vivo imaging with positron emission tomography and using an in vitro model of the human blood-brain barrier. J Pharmacol Exp Ther. 2006;316:79–86
  8. Sharma V, Prior JL, Belinsky MG, Kruh GD, Piwnica-Worms D. Characterization of a 67Ga/68Ga radiopharmaceutical for SPECT and PET of MDR1 P-glycoprotein transport activity in vivo: validation in multidrug-resistant tumors and at the blood-brain barrier. J Nucl Med. 2005;46:354–364
  9. Hawkins BT, Davis TP. The blood-brain barrier/neurovascular unit in health and disease. Pharmacol Rev. 2005;57:173–185
  10. Zlokovic BV. Blood-brain barrier in health and chronic neurodegenerative disorder. Neuron. 2008;57:178–201
  11. Thal DR, Griffin WST, de Vos RAI, Ghebremedhin E. Cerebral amyloid angiopathy and its relationship to Alzheimer's disease. Acta Neuropathol (Berl). 2008;115:599–609
  12. Skoog I, Wallin A, Fredman P, Hesse C, Aevarsson O, Karlsson I, et al. A population study on blood-brain barrier function in 85-year-olds: relation to Alzheimer's disease and vascular dementia. Neurology. 1998;50:966–971
  13. Algotsson A, Winblad B. The integrity of the blood-brain barrier in Alzheimer's disease. Acta Neurol Scand. 2007;115:403–408
  14. Bowman GL, Kaye JA, Moore M, Waichunas D, Carlson NE, Quinn JF. Blood-brain barrier impairment in Alzheimer disease: stability and functional significance. Neurology. 2007;68:1809–1814

PII: S1552-5260(09)02092-5

doi: 10.1016/j.jalz.2009.07.002

Alzheimer's & Dementia: The Journal of the Alzheimer's Association
Volume 5, Issue 5 , Pages 435-436 , September 2009

Article Tools